Key result
Phage-assisted evolution fails to find xanthine riboswitches but generates three theophylline side products.
Why the study?
The study aimed to use an in vivo method to discover riboswitches that are activated by new ligands.
Attempted use of PACE for riboswitch discovery generated three new translational theophylline riboswitch side products but failed to evolve new ligand specificity, highlighting the need to carefully design recombinant M13 phage to avoid 'cheaters'.
Answers are grounded in this paper and cite their sources.
Riboswitch variants may aid tunable synthetic circuits; leaves open whether PACE can evolve new ligand specificities without phage cheaters.
OBJECTIVE: The purpose of this project was to use an in vivo method to discover riboswitches that are activated by new ligands. We employed phage-assisted continuous evolution (PACE) to evolve new riboswitches in vivo. We started with one translational riboswitch and one transcriptional riboswitch, both of which were activated by theophylline. We used xanthine as the new target ligand during positive selection followed by negative selection using theophylline. The goal was to generate very large M13 phage populations that contained unknown mutations, some of which would result in new aptamer specificity. We discovered side products of three new theophylline translational riboswitches with different levels of protein production. RESULTS: We used next generation sequencing to identify M13 phage that carried riboswitch mutations. We cloned and characterized the most abundant riboswitch mutants and discovered three variants that produce different levels of translational output while retaining their theophylline specificity. Although we were unable to demonstrate evolution of new riboswitch ligand specificity using PACE, we recommend careful design of recombinant M13 phage to avoid evolution of "cheaters" that short circuit the intended selection pressure.
No takes yet. Share an insight, caveat, or question.
Shaver et al. (2018) studied this question. Phage-assisted continuous evolution (PACE) was evaluated on Evolution of xanthine-specific riboswitches. Attempted use of phage-assisted continuous evolution to discover xanthine-specific riboswitches failed, but generated three new theophylline-specific translational riboswitch side products.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: